According to AVROBIO's latest financial reports the company's current EPS (TTM) is -$0.13. In 2022 the company made an earnings per share (EPS) of -$2.41 an increase over its 2021 EPS that were of -$2.79.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.13 | -94.61% |
2022 | -$2.41 | -13.62% |
2021 | -$2.79 | -15.71% |
2020 | -$3.31 | 23.51% |
2019 | -$2.68 | -41.86% |
2018 | -$4.61 | 298.36% |
2017 | -$1.16 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 1,576.92% | ๐บ๐ธ USA |